1. Parkinson J. An essay on the shaking palsy. Sherwood, Neely, and Jones; 1817.
2. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39(6):889-909. [
DOI:10.1016/S0896-6273(03)00568-3] [
PMID] [
PMCID]
3. Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912. [
DOI:10.1016/S0140-6736(14)61393-3] [
PMID]
4. Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, et al. Past, present, and future of Parkinson's disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord. 2017;32(9):1264-310. [
DOI:10.1002/mds.27115] [
PMID]
5. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009;373(9680):2055-66. [
DOI:10.1016/S0140-6736(09)60492-X] [
PMID]
6. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease. Neurology. 2009;72(21 Suppl 4):S1-136. [
DOI:10.1212/WNL.0b013e3181a1d44c]
7. Schapira AH. Mitochondrial pathology in Parkinson's disease. Mt Sinai J Med. 2011;78(6):872-81. [
DOI:10.1002/msj.20303] [
PMID]
8. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008;4(11):600-9. [
DOI:10.1038/ncpneuro0924] [
PMID]
9. Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson's disease. J Parkinsons Dis. 2013;3(4):461-91. [
DOI:10.3233/JPD-130230] [
PMID]
10. Bose A, Beal MF. Mitochondrial dysfunction in Parkinson's disease. J Neurochem. 2016;139 Suppl 1:216-31. [
DOI:10.1111/jnc.13731] [
PMID]
11. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 2009;8(4):382-97. [
DOI:10.1016/S1474-4422(09)70062-6] [
PMID]
12. Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010;37(3):510-8. [
DOI:10.1016/j.nbd.2009.11.004] [
PMID]
13. Shimoji M, Pagan F, Healey J, Sanchez-Ramos J. CXCR4 and CXCL12 expression is increased in Parkinson's disease brain. Acta Neuropathol. 2009;118(6):647-58.
14. Miller RJ, Banisadr G, Bhattacharyya BJ. CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol. 2008;198(1-2):31-8. [
DOI:10.1016/j.jneuroim.2008.04.008] [
PMID] [
PMCID]
15. Guyon A. CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems. Front Cell Neurosci. 2014;8:65. [
DOI:10.3389/fncel.2014.00065] [
PMID] [
PMCID]
16. Iciek M, Kwiecień I, Włodek L. Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen. 2009;50(3):247-65. [
DOI:10.1002/em.20474] [
PMID]
17. Corzo-Martínez M, Corzo N, Villamiel M. Biological properties of onions and garlic. Trends Food Sci Technol. 2007;18(12):609-25. [
DOI:10.1016/j.tifs.2007.07.011]
18. Lanzotti V. The analysis of onion and garlic. J Chromatogr A. 2006;1112(1-2):3-22. [
DOI:10.1016/j.chroma.2005.12.016] [
PMID]